Back to 
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
VKTX
7 quarters
Position history for CAPTRUST Financial Advisors's holdings in Viking Therapeutics, Inc.
No. Captrust exited its VKTX (Viking Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 640 shares worth $2,000. Captrust first reported VKTX in Q1 2021 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1,000
Total Shares Change
-210
Quarter-by-Quarter History
Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.